New York, New York-- (Newsfile Corp. - December 3, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Humacyte, Inc. (NASDAQ: HUMA) between May 10, ...
Humacyte Inc’s profitability metrics reveal financial health. The company currently boasts an operating margin of 0.00% with a gross margin of -41.67%. The profit margin, also known as the revenue ...
On Friday, Humacyte Inc (HUMA) stock saw a modest uptick, ending the day at $4.47 which represents a slight increase of $0.07 or 1.59% from the prior close of $4.4. The stock opened at $4.44 and ...
Humacyte, Inc.(纳斯达克股票代码:HUMA)的总裁、首席执行官兼董事Laura E. Niklason最近购买了1,797股公司普通股。这些股票的平均购买价格为每股4.44美元,总交易价值为7,978美元。此次交易后,Niklason直接持有243,851股。此外,她还通过The Niklason Living Trust和Ayabudge LLC等多个实体间接持有股份。